Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease

Background. Exhaled nitric oxide (eNO) is a potential biomarker to distinguish systemic sclerosis (SSc) associated pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD). We evaluated the discriminative validity, feasibility, methods of eNO measurement, and magnitude of difference...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozij, Natalie K., Granton, John T., Silkoff, Philip E., Thenganatt, John, Chakravorty, Shobha, Johnson, Sindhu R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331166/
https://www.ncbi.nlm.nih.gov/pubmed/28293128
http://dx.doi.org/10.1155/2017/6736239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331166/
https://www.ncbi.nlm.nih.gov/pubmed/28293128
http://dx.doi.org/10.1155/2017/6736239

Ejemplares similares